News

“Wegovy is a GLP-1 receptor agonist,” explains ... Lung and Blood Institute’s online BMI calculator. “Most people can expect to lose 10% to 15% of their body weight over a 12-to-18-month ...
COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb ... be eligible for the drug if they have a body mass index (BMI) above 35, or a BMI above 27 ...